Zosano Pharma Corp (ZSAN) [Rocket]

In millions, except per share items	Mar-31-22	Dec-31-21	Sep-30-21	Mar-31-21	Dec-31-20	Sep-30-20	Jun-30-20	Mar-31-20
	10-Q	10-K	10-Q	10-Q	10-K	10-Q	10-Q	10-Q
Assets
Cash and equivalents	13.5	11.0	17.1	26.9	35.3	43.6	10.5	18.6
Accounts receivable, net				0.1
Other current assets	2.1	0.6	1.0	1.5	0.5	0.6	0.7	0.6
Total current assets	15.6	11.6	18.1	28.5	35.7	44.2	11.2	19.2
Property, plant, and equipment, net	7.9	32.6	32.3	32.1	30.9	30.6	30.7	30.2
Other fixed assets				0.0	0.0	0.0	0.0	0.0
Total assets	26.4	48.4	55.0	65.7	72.0	80.5	47.7	55.3

Accounts payable	3.7	2.1	1.6	2.7	1.9	2.0	4.8	3.3
Accrued expenses	2.2	1.8	2.1	1.5	3.4	3.4	3.9	8.9
Short-term debt	0.0	0.0	0.0	1.4	0.8	0.2	0.7	0.0
Short-term debt				1.4	0.8	0.2	0.7
Other current liabilities	3.9	7.2	8.0	8.8	8.5	7.6	7.1	8.4
Total current liabilities	9.7	11.1	11.6	14.4	14.5	13.2	16.5	20.6
Long-term debt				0.2	0.8	1.4	0.9
Other liabilities	2.7	4.3	5.2	7.9	9.2	10.6	11.8	10.8
Total liabilities	12.4	15.4	16.8	22.6	24.5	25.2	29.2	31.4

Shareholders' equity [+]	14.1	33.0	38.2	43.2	47.5	55.2	18.5	24.0
Paid-in capital	409.6	395.1	393.3	383.5	379.7	379.3	333.9	331.5
Retained earnings	-395.5	-362.1	-355.1	-340.3	-332.2	-324.1	-315.4	-307.5
Tangible shareholders' equity	14.1	33.0	38.2	43.2	47.5	55.2	18.5	24.0